ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.807,28
0,68%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07861
0,04%
Bitcoin
63.011,00
-0,06%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Portage Biotech Inc (PRTG)

  7. Portage Biotech Inc (PRTG) News

PRTG

Portage Biotech (PRTG)

Portage Biotech Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRTG
DatumZeitQuelleÜberschriftSymbolFirma
12/04/202414h01GlobeNewswire Inc.Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesNASDAQ:PRTGPortage Biotech Inc
26/03/202413h01GlobeNewswire Inc.Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesNASDAQ:PRTGPortage Biotech Inc
08/03/202423h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
08/03/202423h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
28/02/202423h19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
28/02/202423h10GlobeNewswire Inc.Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateNASDAQ:PRTGPortage Biotech Inc
14/02/202421h50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRTGPortage Biotech Inc
18/01/202423h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
04/01/202414h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
04/01/202414h00GlobeNewswire Inc.Portage Biotech Reports Business and Strategic UpdateNASDAQ:PRTGPortage Biotech Inc
01/12/202322h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTGPortage Biotech Inc
28/11/202322h03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
28/11/202322h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
28/11/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
14/11/202312h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
13/11/202312h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
08/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTGPortage Biotech Inc
07/11/202322h50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
06/11/202314h01GlobeNewswire Inc.Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:PRTGPortage Biotech Inc
31/10/202321h05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRTGPortage Biotech Inc
29/09/202314h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
08/09/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
30/08/202314h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
29/08/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
14/08/202322h52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
31/07/202323h12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRTGPortage Biotech Inc
21/06/202312h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
01/05/202314h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
14/03/202311h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
06/01/202322h50Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PRTG

Kürzlich von Ihnen besucht

CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
FX
EURUSD
Euro vs US Dollar
NASDAQ
AAPL
Apple
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
TG
CBK
Commerzbank
TG
NOV
Novo Nordisk
TG
TUI1
Tui
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MCD
McDonalds
NYSE
NKE
Nike
TG
432
Arbor Metals
AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten